This episode includes an interview with two ID specialty pharmacists and their take on the new Joint Commission requirements that were implemented in 2023. Tune in to learn what they anticipate to be the biggest challenges and opportunities they see from the perspective of a large academic and small community hospital.
Andrea Pallotta, PharmD, (she/her) is the clinical coordinator for infectious diseases and HIV at Cleveland Clinic Main Campus and Antimicrobial Stewardship Lead for the Cleveland Clinic Health System. She is the pharmacy chair for the Antimicrobial and COVID-19 Panels of the Pharmacy and Therapeutics Committee. She works alongside a multidisciplinary team of caregivers to provide treatment for patients living with HIV in outpatient clinic and to coordinate antimicrobial stewardship efforts across the enterprise.
Alex Cain, PharmD, BCIDP, (he/him) is a clinical pharmacy specialist in antimicrobial stewardship at MedStar Montgomery Medical Center located in Olney, Maryland. He received his PharmD from the Wegmans School of Pharmacy at St. John Fisher University. He completed his PGY1 pharmacy residency at UPMC Mercy and completed his PGY2 residency in infectious diseases at Allegheny General Hospital.
Nisha M Mathew, BE, PharmD, MBA, BCPS, CPh, (she/her) is the Cleveland Clinic Florida regional director for medication safety. Dr. Mathew earned her Doctor of Pharmacy from the University of Illinois at Chicago, and completed her PGY1 residency from Froedtert and the Medical College of Wisconsin. She has appointments, as Clinical Assistant Professor at multiple colleges of pharmacy, serves on the ASHP SICP SAG on Medication Management, and is active on several committees at the state level of ASHP. Dr. Mathew is passionate about leadership, advocacy, cardiovascular, and infectious disease topics.